Immunomodulatory effect of cytosine-phosphate-guanosine (CpG)-oligonucleotides in nonasthmatic chronic rhinosinusitis: An explant model

American Journal of Rhinology and Allergy

Volumn 23, Issue 2, 2009, Pages 123-129

  Tan, Lorwai ^a   Rogers, Trisha J ^a   Hatzirodos, Nick ^a   Baker, Leonie M ^a   Ooi, Enghooi ^a   Wormald, Peter John ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Asthma; CpG ODN; Eosinophilic mucus chronic rhinosinusitis; IL 5; Immunostimulatory sequences (ISS); Immunotherapy; Toll like receptor 9

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; CYTOKINE; ENTEROTOXIN; ENTEROTOXIN B; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 5; MESSENGER RNA; PROTEIN P53; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG; CPG ODN 2006; ENTEROTOXIN B, STAPHYLOCOCCAL; IMMUNOLOGIC FACTOR; OLIGODEOXYRIBONUCLEOTIDE; TLR9 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; EXPLANT; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; IN VITRO STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NOSE POLYP; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHINOSINUSITIS; RNA EXTRACTION; SEX DIFFERENCE; STAPHYLOCOCCUS AUREUS; TH2 CELL; COHORT ANALYSIS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PARANASAL SINUS; PATHOLOGY; PATHOPHYSIOLOGY; RESPIRATORY TRACT MUCOSA; RHINITIS; SINUSITIS; TISSUE CULTURE TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; ASTHMA; COHORT STUDIES; ENTEROTOXINS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOLOGIC FACTORS; INTERLEUKIN-5; MALE; MIDDLE AGED; NASAL POLYPS; OLIGODEOXYRIBONUCLEOTIDES; PARANASAL SINUSES; RESPIRATORY MUCOSA; RHINITIS; SINUSITIS; STAPHYLOCOCCUS AUREUS; TISSUE CULTURE TECHNIQUES; TOLL-LIKE RECEPTOR 9;

EID: 67650317890     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2009.23.3279     Document Type: Article

References (32)

1. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: Establishing definitions for clinical research and patient care. J Allergy Clin Immunol 114:155-212, 2004.
2. Pant H, Kette FE, Smith WB, et al. Eosinophilic mucus chronic rhinosinusitis: Clinical subgroups or a homogeneous pathogenic entity? Laryngoscope 116:1241-1247, 2006.
3. Bachert C, Vignola AM, Gevaert P, et al. Allergic rhinitis, rhinosinusitis, and asthma: One airway disease. Immunol Allergy Clin North Am 24:19-43, 2004.
4. Meltzer EO, Szwarcberg J, and Pill MW. Allergic rhinitis, asthma, and rhinosinusitis: Diseases of the integrated airway. J Manag Care Pharm 10:310-317, 2004.
5. Ponikau JU, Sherris DA, Kephart GM, et al. Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: Is the histopathology similar to asthma? J Allergy Clin Immunol 112:877-882, 2003.
6. Krieg AM. Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Discov 5:471-484, 2006.
7. Krieg AM. The role of CpG motifs in innate immunity. Curr Opin Immunol 12:35-43, 2000.
8. Roeder A, Kirschning CJ, Rupec RA, et al. Toll-like receptors and innate antifungal responses. Trends Microbiol 12:44-49, 2004.
9. Wild JS, and Sur S. CpG oligonucleotide modulation of allergic inflammation. Allergy 56:365-376, 2001.
10. Broide D, Schwarze J, Tighe H, et al. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J Immunol 161:7054-7062, 1998.
11. Shirota H, Sano K, Kikuchi T, et al. Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator. J Immunol 164:5575-5582, 2000.
12. Mo JH, Park SW, Rhee CS, et al. Suppression of allergic response by CpG motif oligodeoxynucleotide-house-dust mite conjugate in animal model of allergic rhinitis. Am J Rhinol 20:212-218, 2006.
13. Creticos PS, Schroeder JT, Hamilton RG, et al. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med 355:1445-1455, 2006.
14. Johansen P, Senti G, Martinez Gomez JM, et al. Toll-like receptor ligands as adjuvants in allergen-specific immunotherapy. Clin Exp Allergy 35:1591-1598, 2005.
15. Nelson HS. Advances in upper airway diseases and allergen immunotherapy. J Allergy Clin Immunol 119:872-880, 2007.
16. Wiedermann U, and Mercenier A. New allergy intervention strategies: Hitting the mucosal road. Clin Exp Allergy 37: 473-475, 2007.
17. Takabayashi K, Libet L, Chisholm D, et al. Intranasal immunotherapy is more effective than intradermal immunotherapy for the induction of airway allergen tolerance in Th2-sensitized mice. J Immunol 170:3898-3905, 2003.
18. Ramanathan M Jr, Lee WK, Dubin MG, et al. Sinonasal epithelial cell expression of toll-like receptor 9 is decreased in chronic rhinosinusitis with polyps. Am J Rhinol 21:110-116, 2007.
19. Patou J, Gevaert P, Van Zele T, et al. Staphylococcus aureus enterotoxin B, protein A, and lipoteichoic acid stimulations in nasal polyps. J Allergy Clin Immunol 121:110-115, 2008.
20. Psaltis A, Weitzel E, Ha KR, et al. The effect of bacterial biofilms on post-sinus surgical outcomes. Am J Rhinol 22: 1-6, 2008.
21. Ooi E, Wormald PJ, Carney AS, et al. Human cathelicidin antimicrobial peptide is upregulated in the eosinophilic mucus subgroup of chronic rhinosinusitis patients. Am J Rhinol 21:395-401, 2007.
22. Ooi EH, Wormald PJ, Carney AS, et al. Surfactant protein d expression in chronic rhinosinusitis patients and immune responses in vitro to Aspergillus and Alternaria in a nasal explant model. Laryngoscope 117:51-57, 2007.
23. Livak KJ, and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408, 2001.
24. Hamilos DL. Chronic sinusitis. J Allergy Clin Immunol 106: 213-227, 2000.
25. Ferguson BJ. Eosinophilic mucin rhinosinusitis: A distinct clinicopathological entity. Laryngoscope 110:799-813, 2000.
26. Sobol SE, Fukakusa M, Christodoulopoulos P, et al. Inflammation and remodeling of the sinus mucosa in children and adults with chronic sinusitis. Laryngoscope 113:410-414, 2003.
27. Lee YM, Kim SS, Kim HA, et al. Eosinophil inflammation of nasal polyp tissue: Relationships with matrix metalloproteinases, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta1. J Kor Med Sci 18:97-102, 2003.
28. Tan L, Hatzirodos N, and Wormald PJ. Effect of nerve growth factor and keratinocyte growth factor on wound healing of the sinus mucosa. Wound Repair Regen 16:108-116, 2008.
29. Kline JN, Krieg AM, Waldschmidt TJ, et al. CpG oligodeoxynucleotides do not require TH1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma. J Allergy Clin Immunol 104:1258-1264, 1999.
30. Lane AP, Truong-Tran QA, and Schleimer RP. Altered expression of genes associated with innate immunity and inflammation in recalcitrant rhinosinusitis with polyps. Am J Rhinol 20:138-144, 2006.
31. Wark PA, Johnston SL, Bucchieri F, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 201:937-947, 2005.
32. Petrilli V, Dostert C, Muruve DA, et al. The inflammasome: A danger sensing complex triggering innate immunity. Curr Opin Immunol 19:615-622, 2007.